{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:57:39Z","timestamp":1790816259662,"version":"4.1.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T00:00:00Z","timestamp":1783296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"vor","delay-in-days":87,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100006093","name":"Patient-Centered Outcomes Research Institute","doi-asserted-by":"publisher","award":["P30HS029771"],"award-info":[{"award-number":["P30HS029771"]}],"id":[{"id":"10.13039\/100006093","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Patient Rep Outcomes"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Brain-gut behavior therapies (BGBTs) are evidence-based treatments for patients with disorders of gut-brain interaction (DGBI) and inflammatory bowel disease (IBD). While BGBT clinical trials prioritize decreasing symptom severity and improving anxiety, depression, and quality of life, these outcomes are not designed based on patients\u2019 priorities. We aimed to determine the optimal patient-centered outcome measures to assess change following BGBT using a stakeholder-engaged qualitative process.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We interviewed patients 1:1 with DGBI and IBD with and without BGBT experience. Interview data were analyzed using rapid qualitative analysis. Subsequent focus groups reviewed the qualitative findings to verify accuracy, identify high-priority and missing constructs, and create clinical use recommendations. Measure recommendations were developed based on patients\u2019 perspectives and the extant literature.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Qualitative interviews (\n                      <jats:italic>N<\/jats:italic>\n                      \u2009=\u200920) yielded five domains: lived experience of disease, how to cope with illness, perceived value of behavioral intervention, outcomes and measurement, and behavioral intervention effects. Focus group participants (\n                      <jats:italic>N<\/jats:italic>\n                      \u2009=\u200914) broadly confirmed that the qualitative themes represented their experience with BGBTs and prioritized confidence in symptom management, social connectedness, lived experience with disease, and mental\/behavioral health symptoms. They highlighted the importance of brevity, semi-regular re-evaluation, and access to results. Resultant measures included: Brief Illness Perception Questionnaire, PROMIS Self-Efficacy for Managing Chronic Conditions-Symptoms, UCLA Loneliness Scale, IBD DISK (adapted), and PHQ-2\/GAD-2.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The identified treatment targets differed from those prioritized in clinical trials. However, DGBI and IBD literature suggests that many of the identified constructs supersede traditional outcomes such as anxiety and depression. These results can guide integration of patient-reported outcome measures into gastropsychology programs and highlight the value of involving patients in program development.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s41687-026-01125-x","type":"journal-article","created":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T14:46:27Z","timestamp":1783349187000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Patient Identification of the most important outcomes in a gastrointestinal behavioral health program"],"prefix":"10.1186","volume":"10","author":[{"given":"Robert E.","family":"Brady","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brooke A.","family":"Duarte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corey A.","family":"Siegel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6498-3729","authenticated-orcid":false,"given":"Jessica K.","family":"Salwen-Deremer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,6]]},"reference":[{"issue":"7","key":"1125_CR1","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1111\/apt.17894","volume":"59","author":"OS Palsson","year":"2024","unstructured":"Palsson OS, Tack J, Drossman DA et al (2024) Worldwide population prevalence and impact of sub-diagnostic gastrointestinal symptoms. Aliment Pharmacol Ther 59(7):852\u2013864","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"1125_CR2","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1038\/ajg.2017.421","volume":"113","author":"I Aziz","year":"2018","unstructured":"Aziz I, Palsson OS, T\u00f6rnblom H, Sperber AD, Whitehead WE, Simren M (2018) The prevalence and impact of overlapping Rome IV-diagnosed functional gastrointestinal disorders on somatization, quality of life, and healthcare utilization: a cross-sectional general population study in three countries. Official J Am Coll Gastroenterology| ACG 113(1):86\u201396","journal-title":"Official J Am Coll Gastroenterology| ACG"},{"issue":"12","key":"1125_CR3","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1038\/nrgastro.2015.150","volume":"12","author":"GG Kaplan","year":"2015","unstructured":"Kaplan GG (2015) The global burden of IBD: from 2015 to 2025. Nat reviews Gastroenterol Hepatol 12(12):720","journal-title":"Nat reviews Gastroenterol Hepatol"},{"issue":"5","key":"1125_CR4","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/S2468-1253(21)00014-5","volume":"6","author":"B Barberio","year":"2021","unstructured":"Barberio B, Zamani M, Black CJ, Savarino EV, Ford AC (2021) Prevalence of symptoms of anxiety and depression in patients with inflammatory bowel disease: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol 6(5):359\u2013370","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"2","key":"1125_CR5","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1111\/apt.15325","volume":"50","author":"M Zamani","year":"2019","unstructured":"Zamani M, Alizadeh-Tabari S, Zamani V (2019) Systematic review with meta\u2010analysis: the prevalence of anxiety and depression in patients with irritable bowel syndrome. Aliment Pharmacol Ther 50(2):132\u2013143","journal-title":"Aliment Pharmacol Ther"},{"issue":"11","key":"1125_CR6","doi-asserted-by":"publisher","first-page":"2983","DOI":"10.1007\/s10620-018-5237-7","volume":"63","author":"S Ballou","year":"2018","unstructured":"Ballou S, Alhassan E, Hon E et al (2018) Sleep disturbances are commonly reported among patients presenting to a gastroenterology clinic. Dig Dis Sci 63(11):2983\u20132991","journal-title":"Dig Dis Sci"},{"key":"1125_CR7","doi-asserted-by":"crossref","unstructured":"Arizmendi BJ, Craven MR, Martinez-Camblor P, Tormey LK, Salwen-Deremer JK (2024) Engagement in GI behavioral health is associated with reduced portal messages, phone calls, and, visits ED. Dig Dis Sci 69(6):1939\u20131947","DOI":"10.1007\/s10620-024-08428-3"},{"issue":"10","key":"1125_CR8","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1016\/S2468-1253(20)30215-6","volume":"5","author":"C Basnayake","year":"2020","unstructured":"Basnayake C, Kamm MA, Stanley A et al (2020) Standard gastroenterologist versus multidisciplinary treatment for functional gastrointestinal disorders (MANTRA): an open-label, single-centre, randomised controlled trial. lancet Gastroenterol Hepatol 5(10):890\u2013899","journal-title":"lancet Gastroenterol Hepatol"},{"issue":"8","key":"1125_CR9","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1016\/j.cgh.2021.11.013","volume":"20","author":"L Keefer","year":"2022","unstructured":"Keefer L, Gorbenko K, Siganporia T et al (2022) Resilience-based integrated IBD care is associated with reductions in health care use and opioids. Clin Gastroenterol Hepatol 20(8):1831\u20131838","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"1125_CR10","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1093\/jcag\/gwy060","volume":"3","author":"R Schoenfeld","year":"2018","unstructured":"Schoenfeld R, Nguyen GC, Bernstein CN (2018) Integrated care models: optimizing adult ambulatory care in inflammatory bowel disease. J Can Association Gastroenterol 3(1):44\u201353","journal-title":"J Can Association Gastroenterol"},{"issue":"1","key":"1125_CR11","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1053\/j.gastro.2018.03.063","volume":"155","author":"JM Lackner","year":"2018","unstructured":"Lackner JM, Jaccard J, Keefer L et al (2018) Improvement in Gastrointestinal Symptoms After Cognitive Behavior Therapy for Refractory Irritable Bowel Syndrome. Gastroenterology Jul 155(1):47\u201357. https:\/\/doi.org\/10.1053\/j.gastro.2018.03.063","journal-title":"Gastroenterology Jul"},{"issue":"6","key":"1125_CR12","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.3748\/wjg.v21.i6.1893","volume":"14","author":"SW Kinsinger","year":"2015","unstructured":"Kinsinger SW, Ballou S, Keefer L (2015) Snapshot of an integrated psychosocial gastroenterology service. World J Gastroenterol Feb 14(6):1893\u20131899. https:\/\/doi.org\/10.3748\/wjg.v21.i6.1893","journal-title":"World J Gastroenterol Feb"},{"issue":"7","key":"1125_CR13","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s11894-020-00769-z","volume":"3","author":"OS Palsson","year":"2020","unstructured":"Palsson OS, Ballou S (2020) Hypnosis and Cognitive Behavioral Therapies for the Management of Gastrointestinal Disorders. Curr Gastroenterol Rep Jun 3(7):31. https:\/\/doi.org\/10.1007\/s11894-020-00769-z","journal-title":"Curr Gastroenterol Rep Jun"},{"issue":"9","key":"1125_CR14","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1136\/gutjnl-2018-317805","volume":"68","author":"HA Everitt","year":"2019","unstructured":"Everitt HA, Landau S, O\u2019Reilly G et al (2019) Assessing telephone-delivered cognitive-behavioural therapy (CBT) and web-delivered CBT versus treatment as usual in irritable bowel syndrome (ACTIB): a multicentre randomised trial. Gut Sep 68(9):1613\u20131623. https:\/\/doi.org\/10.1136\/gutjnl-2018-317805","journal-title":"Gut Sep"},{"issue":"4","key":"1125_CR15","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1038\/ajg.2018.15","volume":"113","author":"E Glasinovic","year":"2018","unstructured":"Glasinovic E, Wynter E, Arguero J et al (2018) Treatment of supragastric belching with cognitive behavioral therapy improves quality of life and reduces acid gastroesophageal reflux. Am J Gastroenterol Apr 113(4):539\u2013547. https:\/\/doi.org\/10.1038\/ajg.2018.15","journal-title":"Am J Gastroenterol Apr"},{"issue":"5","key":"1125_CR16","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1111\/apt.15417","volume":"50","author":"A Sawada","year":"2019","unstructured":"Sawada A, Anastasi N, Green A et al (2019) Management of supragastric belching with cognitive behavioural therapy: factors determining success and follow-up outcomes at 6\u201312 months post-therapy. Aliment Pharmacol Ther Sep 50(5):530\u2013537. https:\/\/doi.org\/10.1111\/apt.15417","journal-title":"Aliment Pharmacol Ther Sep"},{"issue":"3","key":"1125_CR17","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.jpsychores.2010.02.005","volume":"69","author":"P Spinhoven","year":"2010","unstructured":"Spinhoven P, Van der Does AJ, Van Dijk E, Van Rood YR (2010) Heart-focused anxiety as a mediating variable in the treatment of noncardiac chest pain by cognitive-behavioral therapy and paroxetine. J Psychosom Res Sep 69(3):227\u2013235. https:\/\/doi.org\/10.1016\/j.jpsychores.2010.02.005","journal-title":"J Psychosom Res Sep"},{"issue":"1","key":"1125_CR18","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s13030-021-00226-x","volume":"27","author":"N Sugaya","year":"2021","unstructured":"Sugaya N, Shirotsuki K, Nakao M (2021) Cognitive behavioral treatment for irritable bowel syndrome: a recent literature review. Biopsychosoc Med Nov 27(1):23. https:\/\/doi.org\/10.1186\/s13030-021-00226-x","journal-title":"Biopsychosoc Med Nov"},{"issue":"9","key":"1125_CR19","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1037\/ccp0000227","volume":"85","author":"F Bennebroek Evertsz","year":"2017","unstructured":"Bennebroek Evertsz F, Sprangers MAG, Sitnikova K et al (2017) Effectiveness of cognitive-behavioral therapy on quality of life, anxiety, and depressive symptoms among patients with inflammatory bowel disease: A multicenter randomized controlled trial. J Consult Clin Psychol Sep 85(9):918\u2013925. https:\/\/doi.org\/10.1037\/ccp0000227","journal-title":"J Consult Clin Psychol Sep"},{"issue":"1","key":"1125_CR20","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1186\/s12876-021-02003-0","volume":"15","author":"J Chen","year":"2021","unstructured":"Chen J, Chen X, Sun Y et al (2021) The physiological and psychological effects of cognitive behavior therapy on patients with inflammatory bowel disease before COVID-19: a systematic review. BMC Gastroenterol Dec 15(1):469. https:\/\/doi.org\/10.1186\/s12876-021-02003-0","journal-title":"BMC Gastroenterol Dec"},{"issue":"1","key":"1125_CR21","doi-asserted-by":"publisher","first-page":"e12699","DOI":"10.1111\/ijn.12699","volume":"25","author":"C Li","year":"2019","unstructured":"Li C, Hou Z, Liu Y, Ji Y, Xie L (2019) Cognitive-behavioural therapy in patients with inflammatory bowel diseases: A systematic review and meta-analysis. Int J Nurs Pract Feb 25(1):e12699. https:\/\/doi.org\/10.1111\/ijn.12699","journal-title":"Int J Nurs Pract Feb"},{"key":"1125_CR22","doi-asserted-by":"publisher","first-page":"114653","DOI":"10.1016\/j.bbr.2023.114653","volume":"2","author":"C Wang","year":"2023","unstructured":"Wang C, Sheng Y, Yu L, Tian F, Xue Y, Zhai Q (2023) Effects of cognitive behavioral therapy on mental health and quality of life in inflammatory bowel disease patients: A meta-analysis of randomized controlled trials. Behav Brain Res Oct 2:454:114653. https:\/\/doi.org\/10.1016\/j.bbr.2023.114653","journal-title":"Behav Brain Res Oct"},{"issue":"2","key":"1125_CR23","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1053\/j.gastro.2007.05.014","volume":"133","author":"JM Lackner","year":"2007","unstructured":"Lackner JM, Jaccard J, Krasner SS, Katz LA, Gudleski GD, Blanchard EB (2007) How does cognitive behavior therapy for irritable bowel syndrome work? A mediational analysis of a randomized clinical trial. Gastroenterology 133(2):433\u2013444","journal-title":"Gastroenterology"},{"issue":"7","key":"1125_CR24","doi-asserted-by":"publisher","first-page":"e70037","DOI":"10.1111\/nmo.70037","volume":"37","author":"EC Adler","year":"2025","unstructured":"Adler EC, Levine EH, Ibarra AN et al (2025) Gut-Directed Hypnotherapy for Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis. Neurogastroenterol Motil Jul 37(7):e70037. https:\/\/doi.org\/10.1111\/nmo.70037","journal-title":"Neurogastroenterol Motil Jul"},{"issue":"6","key":"1125_CR25","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1053\/gast.2002.37071","volume":"123","author":"EL Calvert","year":"2002","unstructured":"Calvert EL, Houghton LA, Cooper P, Morris J, Whorwell PJ (2002) Long-term improvement in functional dyspepsia using hypnotherapy. Gastroenterology Dec 123(6):1778\u20131785. https:\/\/doi.org\/10.1053\/gast.2002.37071","journal-title":"Gastroenterology Dec"},{"issue":"11","key":"1125_CR26","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1136\/gut.2007.132621","volume":"56","author":"V Miller","year":"2007","unstructured":"Miller V, Jones H, Whorwell PJ (2007) Hypnotherapy for non-cardiac chest pain: long-term follow-up. Gut Nov 56(11):1643. https:\/\/doi.org\/10.1136\/gut.2007.132621","journal-title":"Gut Nov"},{"issue":"7","key":"1125_CR27","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1111\/apt.12449","volume":"38","author":"L Keefer","year":"2013","unstructured":"Keefer L, Taft TH, Kiebles JL, Martinovich Z, Barrett TA, Palsson OS (2013) Gut-directed hypnotherapy significantly augments clinical remission in quiescent ulcerative colitis. Aliment Pharmacol Ther Oct 38(7):761\u2013771. https:\/\/doi.org\/10.1111\/apt.12449","journal-title":"Aliment Pharmacol Ther Oct"},{"issue":"11","key":"1125_CR28","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1111\/apt.13202","volume":"41","author":"SL Peters","year":"2015","unstructured":"Peters SL, Muir JG, Gibson PR (2015) Review article: gut-directed hypnotherapy in the management of irritable bowel syndrome and inflammatory bowel disease. Aliment Pharmacol Ther Jun 41(11):1104\u20131115. https:\/\/doi.org\/10.1111\/apt.13202","journal-title":"Aliment Pharmacol Ther Jun"},{"issue":"9453","key":"1125_CR29","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/s0140-6736(04)17670-8","volume":"365","author":"PM Rothwell","year":"2005","unstructured":"Rothwell PM (2005) External validity of randomised controlled trials: to whom do the results of this trial apply? Lancet Jan 1\u20137 365(9453):82\u201393. https:\/\/doi.org\/10.1016\/s0140-6736(04)17670-8","journal-title":"Lancet Jan 1\u20137"},{"issue":"3","key":"1125_CR30","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1093\/clipsy.bpg025","volume":"10","author":"MJ Lambert","year":"2003","unstructured":"Lambert MJ, Whipple JL, Hawkins EJ, Vermeersch DA, Nielsen SL, Smart DW (2003) Is it time for clinicians to routinely track patient outcome? A meta-analysis. Clin Psychol Sci Pract 10(3):288","journal-title":"Clin Psychol Sci Pract"},{"issue":"1","key":"1125_CR31","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1007\/s10488-016-0763-0","volume":"45","author":"A Jensen-Doss","year":"2018","unstructured":"Jensen-Doss A, Haimes EMB, Smith AM et al (2018) Monitoring Treatment Progress and Providing Feedback is Viewed Favorably but Rarely Used in Practice. Adm Policy Ment Health Jan 45(1):48\u201361. https:\/\/doi.org\/10.1007\/s10488-016-0763-0","journal-title":"Adm Policy Ment Health Jan"},{"key":"1125_CR32","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/1477-7525-4-79","volume":"11","author":"Guidance for industry","year":"2006","unstructured":"Guidance for industry (2006): patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance. Health Qual Life Outcomes Oct 11:4:79. https:\/\/doi.org\/10.1186\/1477-7525-4-79","journal-title":"Health Qual Life Outcomes Oct"},{"issue":"7414","key":"1125_CR33","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1136\/bmj.327.7414.542","volume":"6","author":"RE Say","year":"2003","unstructured":"Say RE, Thomson R (2003) The importance of patient preferences in treatment decisions\u2013challenges for doctors. Bmj Sep 6(7414):542\u2013545. https:\/\/doi.org\/10.1136\/bmj.327.7414.542","journal-title":"Bmj Sep"},{"key":"1125_CR34","doi-asserted-by":"publisher","unstructured":"Charles C, Gafni A, Whelan T (1999 Sep) Decision-making in the physician-patient encounter: revisiting the shared treatment decision-making model. Soc Sci Med 49(5):651\u2013661. https:\/\/doi.org\/10.1016\/s0277-9536(99)00145-8","DOI":"10.1016\/s0277-9536(99)00145-8"},{"key":"1125_CR35","doi-asserted-by":"publisher","unstructured":"Boaz A, Hanney S, Borst R, O\u2019Shea A, Kok M (2018) How to engage stakeholders in research: design principles to support improvement. Health Res Policy Syst 16(1):60. https:\/\/doi.org\/10.1186\/s12961-018-0337-6","DOI":"10.1186\/s12961-018-0337-6"},{"issue":"2","key":"1125_CR36","doi-asserted-by":"publisher","first-page":"181","DOI":"10.2217\/cer.12.7","volume":"1","author":"PA Deverka","year":"2012","unstructured":"Deverka PA, Lavallee DC, Desai PJ et al (2012) Stakeholder participation in comparative effectiveness research: defining a framework for effective engagement. J Comp Eff Res Mar 1(2):181\u2013194. https:\/\/doi.org\/10.2217\/cer.12.7","journal-title":"J Comp Eff Res Mar"},{"issue":"2","key":"1125_CR37","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1111\/j.1752-8062.2010.00184.x","volume":"3","author":"HP Selker","year":"2010","unstructured":"Selker HP, Leslie LK, Wasser JS, Plaut AG, Wilson IB, Griffith JL (2010) Tufts CTSI: comparative effectiveness research as a conceptual framework for a focus on impact. Clin Transl Sci Apr 3(2):56\u201358. https:\/\/doi.org\/10.1111\/j.1752-8062.2010.00184.x","journal-title":"Clin Transl Sci Apr"},{"key":"1125_CR38","doi-asserted-by":"publisher","unstructured":"Concannon TW, Meissner P, Grunbaum JA et al (2012 Aug) A new taxonomy for stakeholder engagement in patient-centered outcomes research. J Gen Intern Med 27(8):985\u2013991. https:\/\/doi.org\/10.1007\/s11606-012-2037-1","DOI":"10.1007\/s11606-012-2037-1"},{"key":"1125_CR39","doi-asserted-by":"publisher","unstructured":"Concannon TW, Fuster M, Saunders T et al (2014 Dec) A systematic review of stakeholder engagement in comparative effectiveness and patient-centered outcomes research. J Gen Intern Med 29(12):1692\u20131701. https:\/\/doi.org\/10.1007\/s11606-014-2878-x","DOI":"10.1007\/s11606-014-2878-x"},{"issue":"10","key":"1125_CR40","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1177\/1049732320921835","volume":"30","author":"C Vindrola-Padros","year":"2020","unstructured":"Vindrola-Padros C, Johnson GA (2020) Rapid Techniques in Qualitative Research: A Critical Review of the Literature. Qual Health Res 30(10):1596\u20131604. https:\/\/doi.org\/10.1177\/1049732320921835","journal-title":"Qual Health Res"},{"key":"1125_CR41","doi-asserted-by":"publisher","first-page":"112516","DOI":"10.1016\/j.psychres.2019.112516","volume":"280","author":"AB Hamilton","year":"2019","unstructured":"Hamilton AB, Finley EP (2019) Qualitative methods in implementation research: An introduction. Psychiatry Res Oct 280:112516. https:\/\/doi.org\/10.1016\/j.psychres.2019.112516","journal-title":"Psychiatry Res Oct"},{"issue":"1","key":"1125_CR42","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s13012-024-01397-1","volume":"2024\/10\/11","author":"CP Kowalski","year":"2024","unstructured":"Kowalski CP, Nevedal AL, Finley EP et al (2024) Planning for and Assessing Rigor in Rapid Qualitative Analysis (PARRQA): a consensus-based framework for designing, conducting, and reporting. Implement Sci 2024\/10\/11(1):71. https:\/\/doi.org\/10.1186\/s13012-024-01397-1","journal-title":"Implement Sci"},{"key":"1125_CR43","first-page":"589","volume-title":"Group Depth Interviews: Focus Group Research","author":"DW Stewart","year":"2009","unstructured":"Stewart DW, Shamdasani PN, Rook DW, Bickman L, Rog DJ (2009) Group Depth Interviews: Focus Group Research, 2 edn. SAGE, Incorporated, pp 589\u2013616","edition":"2"},{"key":"1125_CR44","unstructured":"Research V. How to Estimate the Length of a Survey. https:\/\/verstaresearch.com\/newsletters\/how-to-estimate-the-length-of-a-survey\/. Accessed 12\/18\/25."},{"key":"1125_CR45","unstructured":"CloudResearch A. Simple Formula for Predicting the Time to Complete a Study on Mechanical Turk. https:\/\/www.cloudresearch.com\/resources\/blog\/a-simple-formula-for-predicting-the-time-to-complete-a-study-on-mechanical-turk\/. Accessed 12\/18\/2025."},{"issue":"6","key":"1125_CR46","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.jpsychores.2005.10.020","volume":"60","author":"E Broadbent","year":"2006","unstructured":"Broadbent E, Petrie KJ, Main J, Weinman J (2006) The brief illness perception questionnaire. J Psychosom Res 60(6):631\u2013637","journal-title":"J Psychosom Res"},{"issue":"7","key":"1125_CR47","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1007\/s11136-017-1527-3","volume":"26","author":"AL Gruber-Baldini","year":"2017","unstructured":"Gruber-Baldini AL, Velozo C, Romero S, Shulman LM (2017) Validation of the PROMIS\u00ae measures of self-efficacy for managing chronic conditions. Qual Life Res 26(7):1915\u20131924","journal-title":"Qual Life Res"},{"issue":"6","key":"1125_CR48","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1177\/0164027504268574","volume":"26","author":"ME Hughes","year":"2004","unstructured":"Hughes ME, Waite LJ, Hawkley LC, Cacioppo JT (2004) A short scale for measuring loneliness in large surveys: Results from two population-based studies. Res Aging 26(6):655\u2013672","journal-title":"Res Aging"},{"issue":"3","key":"1125_CR49","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1097\/MIB.0000000000001033","volume":"23","author":"S Ghosh","year":"2017","unstructured":"Ghosh S, Louis E, Beaugerie L et al (2017) Development of the IBD disk: a visual self-administered tool for assessing disability in inflammatory bowel diseases. Inflamm Bowel Dis 23(3):333\u2013340","journal-title":"Inflamm Bowel Dis"},{"key":"1125_CR50","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.genhosppsych.2018.11.003","volume":"56","author":"LG Staples","year":"2019","unstructured":"Staples LG, Dear BF, Gandy M et al (2019) Psychometric properties and clinical utility of brief measures of depression, anxiety, and general distress: The PHQ-2, GAD-2, and K-6. Gen Hosp Psychiatry 56:13\u201318","journal-title":"Gen Hosp Psychiatry"},{"key":"1125_CR51","doi-asserted-by":"crossref","unstructured":"MacKrill K, Bass C, Petrie K (2025) Comparing illness perceptions in inflammatory bowel disease and irritable bowel syndrome. J Psychosom Res 112337","DOI":"10.1016\/j.jpsychores.2025.112337"},{"key":"1125_CR52","doi-asserted-by":"crossref","unstructured":"Zhang M, Hong L, Zhang T et al (2016) Illness perceptions and stress: mediators between disease severity and psychological well-being and quality of life among patients with Crohn\u2019s disease. Patient Prefer Adherence 2387\u20132396","DOI":"10.2147\/PPA.S118413"},{"key":"1125_CR53","doi-asserted-by":"publisher","first-page":"110596","DOI":"10.1016\/j.jpsychores.2021.110596","volume":"149","author":"J Kantidakis","year":"2021","unstructured":"Kantidakis J, Moulding R, Knowles S (2021) Psychological mediators of psychological distress and quality of life in inflammatory bowel disease. J Psychosom Res 149:110596","journal-title":"J Psychosom Res"},{"issue":"10","key":"1125_CR54","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1016\/j.brat.2013.07.007","volume":"51","author":"J Chilcot","year":"2013","unstructured":"Chilcot J, Moss-Morris R (2013) Changes in illness-related cognitions rather than distress mediate improvements in irritable bowel syndrome (IBS) symptoms and disability following a brief cognitive behavioural therapy intervention. Behav Res Ther 51(10):690\u2013695","journal-title":"Behav Res Ther"},{"issue":"12","key":"1125_CR55","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1093\/abm\/kaae055","volume":"58","author":"EJ Ross","year":"2024","unstructured":"Ross EJ, Shanahan ML, Joseph E et al (2024) The relationship between loneliness, social isolation, and inflammatory bowel disease: a narrative review. Ann Behav Med 58(12):779\u2013788","journal-title":"Ann Behav Med"},{"key":"1125_CR56","doi-asserted-by":"crossref","unstructured":"Zhou T, Jin Z, Ye K, Shen Z (2025) Social isolation, loneliness, and incident irritable bowel syndrome: a prospective cohort study","DOI":"10.21203\/rs.3.rs-6465123\/v1"},{"key":"1125_CR57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.genhosppsych.2023.01.004","volume":"81","author":"EN Madva","year":"2023","unstructured":"Madva EN, Sadlonova M, Harnedy LE et al (2023) Positive psychological well-being and clinical characteristics in IBS: A systematic review. Gen Hosp Psychiatry 81:1\u201314","journal-title":"Gen Hosp Psychiatry"},{"issue":"4","key":"1125_CR58","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/j.gtc.2022.06.011","volume":"51","author":"HB Murray","year":"2022","unstructured":"Murray HB, Lj\u00f3tsson B (2022) Future of brain\u2013gut behavior therapies: Mediators and moderators. Gastroenterol Clin North Am 51(4):723\u2013739","journal-title":"Gastroenterol Clin North Am"},{"issue":"6","key":"1125_CR59","doi-asserted-by":"publisher","first-page":"e00577","DOI":"10.14309\/ctg.0000000000000577","volume":"14","author":"JL Sheehan","year":"2023","unstructured":"Sheehan JL, Greene-Higgs L, Swanson L et al (2023) Self-efficacy and the impact of inflammatory bowel disease on patients\u2019 daily lives. Clin translational Gastroenterol 14(6):e00577","journal-title":"Clin translational Gastroenterol"}],"container-title":["Journal of Patient-Reported Outcomes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41687-026-01125-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41687-026-01125-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41687-026-01125-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T23:58:19Z","timestamp":1790812699000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s41687-026-01125-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,6]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1125"],"URL":"https:\/\/doi.org\/10.1186\/s41687-026-01125-x","relation":{},"ISSN":["2509-8020"],"issn-type":[{"value":"2509-8020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,6]]},"assertion":[{"value":"5 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study received approval from the Dartmouth Health Human Research Protection Program (STUDY02002211). All participants provided informed consent prior to engaging in any study activities and all research activities were conducted in accordance with the Declaration of Helsinki.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"175"}}